Your session is about to expire
← Back to Search
Behavioral Intervention for Alcohol Use Disorder
Study Summary
This trial will study whether the addition of a behavioral intervention called Strengths-based Linkage to Alcohol Care (SLAC) to usual care can help Veterans with hazardous drinking and posttraumatic stress disorders (PTSD) or depression.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You have not received treatment for substance abuse or attended support groups for the past 90 days.You have experienced symptoms of PTSD or depression in the past year and have had positive rescreens.
- Group 1: Usual care
- Group 2: Strengths-based linkage to alcohol care (SLAC)
Frequently Asked Questions
How many people can take part in this experiment at once?
"Confirmed. According to information posted on clinicaltrials.gov, this medical trial is actively recruiting and was first advertised on February 1st 2022. A total of 140 patients are needed from 2 different medical centres for the study's completion."
Are any openings available for prospective participants in this trial?
"Correct. According to clinicaltrials.gov, this medical study is indeed recruiting patients; it was first listed on February 1st 2022 and updated 4 days later. The aim of the trial is to enrol 140 individuals at two distinct sites."
Are there any official recognitions for Strengths-based linkages to alcohol care?
"The safety of Strengths-based linkage to alcohol care has been rated a 1 on the Power team's scale due to its Phase 1 status, signifying that there is limited evidence supporting it in terms of both efficacy and security."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger